Advisor Group Holdings, Inc. Foghorn Therapeutics Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,001 shares of FHTX stock, worth $4,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,001
Previous 1
100000.0%
Holding current value
$4,214
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FHTX
# of Institutions
83Shares Held
37MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$53.4 Million23.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$22.3 Million0.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$13.7 Million0.35% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.37MShares$9.97 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.67 Million0.01% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $175M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...